From: The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data
Metabolic syndrome components | All | Intervention | Control | p value (I vs. C) | ||||
---|---|---|---|---|---|---|---|---|
 | Male , (n = 36) | Female, (n = 46) | Male , (n = 21) | Female , (n = 21) | Male , (n = 15) | Female , (n = 25) | Male, | Female |
Waist circumference(cm) | 109.0 ± 8.7 | 102.8 ± 11.5 | 108.5 ± 7.6 | 99.2 ± 10.5 | 109.6 ± 10.3 | 105.8 ± 11.7 | p = 0.669 | p = 0.055 |
Systolic BP (mmHg) | 134.9 ± 13.7 | 130.5 ± 16.6 | 135.3 ± 11.7 | 134.4 ± 14.8 | 134.3 ± 16.6 | 127.2 ± 17.5 | p = 0.822 | p = 0.140 |
Diastolic BP (mmHg) | 86.3 ± 9.6 | 85.5 ± 9.6 | 86.1 ± 10.6 | 85.1 ± 9.0 | 86.6 ± 8.4 | 85.8 ± 10.2 | p = 0.890 | p = 0.783 |
HDL cholesterol (mmol/l) | 1.15 [1.00 - 1.40] | 1.20 [1.10 - 1.50] | 1.20 [1.00 - 1.40] | 1.30 [1.10 - 1.80] | 1.10 [0.90 - 1.50] | 1.20 [1.10 - 1.45] | p = 0.528 | p = 0.238 |
Triglycerides (mmol/l) | 1.50 [1.05 - 2.10] | 1.60 [1.20 - 2.00] | 1.40 [0.90 - 2.10] | 1.60 [1.00 - 1.80] | 1.60 [1.20 - 2.20] | 1.70 [1.40 - 2.10] | p = 0.541 | p = 0.116 |
FPG (mmol/l) | 5.29 ± 0.53 | 5.15 ± 0.57 | 5.36 ± 0.47 | 5.11 ± 0.38 | 5.19 ± 0.61 | 5.19 ± 0.70 | p = 0.339 | p = 0.611 |
Proportion meeting IDF criteria for: | Â | Â | Â | Â | Â | Â | Â | Â |
   BP | 31 (86.1) | 42 (91.3) | 17 (81.0) | 20 (95.2) | 14 (93.3) | 22 (88.0) | p = 0.376 | p = 0.614 |
   FPG | 11 (30.6) | 11 (23.9) | 8 (38.1) | 4 (19.0) | 3 (20.0) | 7 (28.0) | p = 0.295 | p = 0.717 |
   HDL | 29 (80.6) | 43 (93.5) | 16 (76.2) | 19 (90.5) | 13 (86.7) | 24 (96.0) | p = 0.674 | p = 0.585 |
   Triglycerides | 32 (88.9) | 35 (76.1) | 18 (85.7) | 17 (81.0) | 14 (93.3) | 18 (72.0) | p = 0.626 | p = 0.717 |
Total no of IDF criteria met: | Â | Â | Â | Â | Â | Â | Â | Â |
   3 | 12 (33.3) | 13 (28.3) | 8 (38.1) | 5 (23.8) | 4 (26.7) | 8 (32.0) | p = 0.903 | p = 0.636 |
   4 | 17 (47.2) | 27 (58.7) | 9 (42.9) | 14 (66.7) | 8 (53.3) | 13 (52.0) |  |  |
   5 | 7 (19.4) | 6 (13.0) | 4 (19.0) | 2 (9.5) | 3 (20.0) | 4 (16.0) |  |  |